Etoricoxib Viso Farmaceutica 60 mg film-coated tablets EFG

Package leaflet: Information for the user

Introduction

Package leaflet: information for the patient

Etoricoxib Viso Farmacéutica 30 mg film-coated tablets EFG

Etoricoxib Viso Farmacéutica 60 mg film-coated tablets EFG

Etoricoxib Viso Farmacéutica 90 mg film-coated tablets EFG

Etoricoxib Viso Farmacéutica 120 mg film-coated tablets EFG

Read the entire leaflet carefully before you start taking this medicine, because it contains important information for you.

• Keep this leaflet, as you may need to read it again.
• If you have any questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only, and you should not give it to other people, even if they have the same symptoms as you, because it may harm them.
• If you experience any adverse effects, consult your doctor or pharmacist, even if they are adverse effects not listed in this leaflet. See section 4.

Leaflet contents:

1. What Etoricoxib Viso Farmacéutica tablets are and what they are used for
2. What you need to know before taking Etoricoxib Viso Farmacéutica tablets
3. How to take Etoricoxib Viso Farmacéutica tablets
4. Possible side effects
5. How to store Etoricoxib Viso Farmacéutica tablets
6. Contents of the pack and other information

1. What Etoricoxib Viso Farmacéutica tablets are and what they are used for

What is Etoricoxib?

• Etoricoxib contains the active substance etoricoxib. Etoricoxib belongs to a group of medicines known as selective COX-2 inhibitors. These belong to a family of medicines called nonsteroidal anti-inflammatory drugs (NSAIDs).

What is Etoricoxib used for?

• Etoricoxib helps reduce pain and swelling (inflammation) in the joints and muscles of people aged 16 years and older with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and gout.
• Etoricoxib is also used for short-term treatment of moderate pain following dental surgery in people aged 16 years and older.

What is osteoarthritis?

Osteoarthritis is a joint disease. It causes gradual breakdown of the cartilage that cushions the ends of bones. This leads to swelling (inflammation), pain, tenderness, stiffness, and loss of function.

What is rheumatoid arthritis?

Rheumatoid arthritis is a long-term inflammatory joint disease. It causes pain, stiffness, swelling, and progressive loss of mobility in affected joints. It can also cause inflammation in other parts of the body.

What is gout?

Gout is a condition characterized by sudden and recurring attacks of very painful inflammation and redness in the joints. It is caused by deposits of mineral crystals in the joint.

What is ankylosing spondylitis?

Ankylosing spondylitis is an inflammatory disease affecting the spine and large joints.

2. What you need to know before taking Etoricoxib Viso Farmacéutica tablets

Do not take Etoricoxib Viso Farmacéutica:

• if you are allergic (hypersensitive) to etoricoxib or to any of the other ingredients of this medicine (listed in section 6)
• if you are allergic to non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin and COX-2 inhibitors (see Possible side effects, section 4)
• if you currently have a stomach or duodenal ulcer or gastrointestinal bleeding
• if you have severe liver disease
• if you have severe kidney disease
• if you are or may be pregnant, or are breastfeeding (see "Pregnancy, breastfeeding and fertility")
• if you are under 16 years of age
• if you have inflammatory bowel disease, such as Crohn's disease, ulcerative colitis, or colitis
• if you have uncontrolled high blood pressure (consult your doctor or nurse if you are unsure whether your blood pressure is adequately controlled)
• if your doctor has diagnosed you with heart problems, including heart failure (moderate or severe), or angina pectoris (chest pain)
• if you have had a myocardial infarction, surgical revascularization, or peripheral arterial disease (poor circulation in legs or feet due to narrowed or blocked arteries)
• if you have had any type of stroke (including transient ischemic attack or ischemic cerebrovascular accident).

Etoricoxib may slightly increase your risk of myocardial infarction and stroke, and therefore should not be used in patients who have already experienced heart problems or a stroke.

If you think any of these situations apply to you, do not take the tablets until you have consulted your doctor.

Warnings and precautions

Consult your doctor or pharmacist before starting to take Etoricoxib if:

• You have a history of stomach ulcers or gastrointestinal bleeding.
• You are dehydrated, for example, due to a prolonged illness with vomiting or diarrhea.
• You have swelling due to fluid retention.
• You have a history of heart failure or any other form of heart disease.
• You have a history of high blood pressure. Etoricoxib may increase blood pressure in some people, especially at high doses, and your doctor may want to monitor your blood pressure periodically.
• You have a history of liver or kidney disease.
• You are being treated for an infection. Etoricoxib may mask or conceal fever, which is a sign of infection.
• You have diabetes, high cholesterol, or are a smoker, as these may increase your risk of heart disease.
• You are a woman trying to become pregnant.
• You are over 65 years of age.

If you are unsure whether any of the above conditions apply to you, talk to your doctor before taking this medicine to confirm whether etoricoxib is suitable for you.

Etoricoxib works equally well in young and older adult patients. If you are over 65 years of age, your doctor will want to monitor you appropriately. Dose adjustment is not necessary in patients over 65 years of age.

Children and adolescents

Do not give this medicine to children or adolescents under 16 years of age.

Taking Etoricoxib Viso Farmacéutica with other medicines

Inform your doctor or pharmacist if you are using, have recently used, or might need to use any other medicines, including those obtained without a prescription.

In particular, if you are taking any of the following medicines, your doctor may want to monitor you to ensure your medications remain effective once you start taking Etoricoxib:

• medicines that thin your blood (anticoagulants), such as warfarin

• rifampicin (an antibiotic)

• methotrexate (a medicine used to suppress the immune system and often used in rheumatoid arthritis)

• cyclosporine or tacrolimus (medicines used to suppress the immune system)

• lithium (a medicine used to treat certain types of depression)

• medicines used to help control high blood pressure and heart failure known as ACE inhibitors and angiotensin receptor antagonists, for example enalapril and ramipril, losartan and valsartan

• diuretics (water tablets)

• digoxin (a medicine for heart failure and irregular heartbeat)

• minoxidil (a medicine used to treat high blood pressure)

• oral tablets or solution of salbutamol (a medicine for asthma)

• oral contraceptives (the combination may increase your risk of adverse effects)

• hormone replacement therapy (the combination may increase your risk of adverse effects)

• acetylsalicylic acid (aspirin); the risk of stomach ulcers is higher if you take Etoricoxib with acetylsalicylic acid.

• Acetylsalicylic acid for prevention of myocardial infarction or stroke:

Etoricoxib may be taken with low doses of aspirin. If you are currently taking low-dose aspirin to prevent myocardial infarction or stroke, do not stop taking aspirin without first talking to your doctor.

• Acetylsalicylic acid and other non-steroidal anti-inflammatory drugs (NSAIDs):

do not take high doses of aspirin or other anti-inflammatory medicines while taking this medicine.

Taking Etoricoxib Viso Farmacéutica with food and drinks

The onset of Etoricoxib's effect may be faster if taken without food.

Pregnancy, breastfeeding and fertility

Pregnancy

Etoricoxib tablets should not be taken during pregnancy. Do not take the tablets if you are pregnant, think you may be pregnant, or plan to become pregnant. If you become pregnant, stop taking the tablets and consult your doctor. Speak to your doctor if you have any doubts or need further information.

Breastfeeding

It is not known whether Etoricoxib is excreted in human milk. If you are breastfeeding or plan to breastfeed, consult your doctor before taking Etoricoxib. If you are taking this medicine, you should not breastfeed.

Fertility

Etoricoxib is not recommended for use in women who are trying to become pregnant.

Driving and using machines

Dizziness and somnolence have been reported in some patients taking Etoricoxib.

Do not drive if you experience dizziness or somnolence.

Do not operate tools or machinery if you experience dizziness or somnolence.

3. How to take Etoricoxib Viso Farmacéutica tablets

Follow exactly the instructions given by your doctor for taking this medicine. If you are unsure, consult your doctor or pharmacist again.

Do not take more than the recommended dose for your condition. Your doctor will want to review your treatment from time to time. It is important to use the lowest dose that controls your pain and you should not take Etoricoxib for longer than necessary. This is because the risk of heart attacks and strokes may increase after long-term treatment, especially with high doses.

Different doses of this medicine are available, and depending on your condition, your doctor will prescribe the tablet with the dose appropriate for you.

The recommended dose is:

Osteoarthritis

The recommended dose is 30 mg once daily, increasing up to a maximum of 60 mg once daily if necessary.

Rheumatoid arthritis

The recommended dose is 60 mg once daily, increasing up to a maximum of 90 mg once daily if necessary.

Ankylosing spondylitis

The recommended dose is 60 mg once daily, which may be increased up to a maximum of 90 mg once daily if necessary.

Acute pain situations

Etoricoxib should only be used during the period of acute pain.

Gout

The recommended dose is 120 mg once daily, which should only be used during the period of acute pain, limited to a maximum of 8 days of treatment.

Postoperative dental surgery pain

The recommended dose is 90 mg once daily, limited to a maximum of 3 days of treatment.

Patients with liver problems

• If you have mild liver disease, you must not take more than 60 mg per day.
• If you have moderate liver disease, you must not take more than 30 mg per day.

Use in children and adolescents

Children or adolescents under 16 years of age must not take Etoricoxib tablets.

Patients over 65 years of age

Dose adjustment is not necessary in patients over 65 years of age. As with other medicines, caution should be exercised in elderly patients.

Method of administration

This medicine is administered orally. Take the tablets once daily. Etoricoxib may be taken with or without food.

If you take more Etoricoxib than you should

Never take more tablets than your doctor has recommended. If you take too many Etoricoxib tablets, seek immediate medical attention.

In case of overdose or accidental ingestion, you may also call the Toxicology Information Service at phone number 91 562 04 20, indicating the medication and the amount taken. It is recommended to bring the medicine package and leaflet to the healthcare professional.

If you forget to take Etoricoxib

It is important that you take this medicine exactly as your doctor has instructed. If you miss a dose, simply resume your regular dosing schedule the next day. Do not take a double dose to make up for missed doses.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible adverse effects

Like all medicines, this medicine can cause adverse effects, although not everyone will experience them.

If you develop any of the following symptoms, stop taking this medicine and speak to your doctor immediately (see section 2. What you need to know before taking Etoricoxib):

• difficulty breathing, chest pain, or ankle swelling, or if these worsen
• yellowing of the skin and eyes (jaundice) – these are signs of liver problems
• severe or persistent stomach pain or black stools
• an allergic reaction – which may include skin problems such as ulcers or blistering, or swelling of the face, lips, tongue, or throat that may cause difficulty breathing

The frequency of the possible adverse effects listed below is defined according to the following convention:

Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Very rare (may affect up to 1 in 10,000 people)

The following adverse effects may occur during treatment with Etoricoxib:

Very common:

• stomach pain

Common:

• dry socket (inflammation and pain following tooth extraction)
• swelling of the legs and/or feet due to fluid retention (oedema)
• dizziness, headache
• palpitations (rapid or irregular heartbeat), irregular heart rhythm (arrhythmia)
• high blood pressure
• wheezing or difficulty breathing (bronchospasm)
• constipation, gas (excess wind), gastritis (inflammation of the inner lining of the stomach), heartburn, diarrhoea, indigestion (dyspepsia)/stomach discomfort, nausea, vomiting, inflammation of the oesophagus, mouth ulcers
• changes in blood tests related to your liver
• bruising
• weakness and fatigue, flu-like illness

Uncommon:

• gastroenteritis (inflammation of the gastrointestinal tract affecting both the stomach and small intestine/gastric flu), cold, urinary tract infection
• changes in laboratory results (reduced number of red blood cells, reduced number of white blood cells, decreased platelets)
• hypersensitivity (allergic reaction including hives, which may be severe enough to require immediate medical attention)
• increased or decreased appetite, weight gain
• anxiety, depression, reduced mental sharpness; seeing, feeling, or hearing things that are not there (hallucinations)
• altered taste, inability to sleep, numbness or tingling, drowsiness
• blurred vision, eye irritation and redness
• ringing in the ears, dizziness (sensation of spinning while standing still)
• abnormal heart rhythm (atrial fibrillation), rapid heart rate, heart failure, sensation of tightness, pressure, or heaviness in the chest (angina), myocardial infarction
• flushing, stroke, mini-stroke (transient ischaemic attack), severe increase in blood pressure, inflammation of blood vessels
• cough, shortness of breath, nosebleed
• stomach swelling, changes in bowel habits, dry mouth, stomach ulcer, inflammation of the inner lining of the stomach which may become severe and lead to bleeding, irritable bowel syndrome, inflammation of the pancreas
• swelling of the face, skin rash or itching, skin redness
• muscle cramps/spasms, muscle pain/stiffness
• elevated levels of potassium in your blood, changes in blood or urine tests related to your kidneys, serious kidney problems
• chest pain

Rare:

• angioedema (allergic reaction with swelling of the face, lips, tongue, and/or throat that may cause difficulty breathing or swallowing, which may be severe enough to require immediate medical attention)/anaphylactic/anaphylactoid reactions including shock (severe allergic reaction requiring immediate medical attention)

• confusion, restlessness

• liver problems (hepatitis)

• low levels of sodium in the blood

• liver impairment, yellowing of the skin and/or eyes (jaundice)

• serious skin reactions

Reporting of adverse effects: If you experience any adverse effect, talk to your doctor or pharmacist, even if it is a possible adverse effect not listed in this leaflet. You can also report them directly via the Spanish Pharmacovigilance System for Human Medicines: https://www.notificaram.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Storage of Etoricoxib Viso Farmacéutica

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of that month.

Store below 30°C.

Medicines must not be disposed of via wastewater drains or household waste. Dispose of unused containers and medicines at the SIGRE Point at your pharmacy. If in doubt, ask your pharmacist how to dispose of unused containers and medicines. This will help protect the environment.

6. Contents of the pack and other information

Composition of Etoricoxib Viso Farmacéutica

• The active substance is etoricoxib. Each film-coated tablet contains 30 mg, 60 mg, 90 mg or 120 mg of etoricoxib.

• The other components are:

Tablet core: Anhydrous dicalcium phosphate (Calipharm A), microcrystalline cellulose (Avicel PH 101), sodium croscarmellose (Ac-di-sol), magnesium stearate, microcrystalline cellulose (Avicel PH 200 LM)

Tablet coating:

For 30 mg, 60 mg and 120 mg

Hypromellose, titanium dioxide (E171), macrogol, indigo carmine aluminium lake (E132), iron oxide yellow (E172), isopropyl alcohol, methylene chloride (dichloromethane)

For 90 mg

Hypromellose, titanium dioxide (E171), macrogol, isopropyl alcohol, methylene chloride (dichloromethane)

Nature of the product and contents of the container

Etoricoxib Viso Farmacéutica tablets are available in four strengths:

30 mg tablets: biconvex, round, film-coated tablets, blue-green in colour, marked “11” on one side and “G” on the other, approximately 6 mm in diameter.

60 mg tablets: biconvex, round, film-coated tablets, dark green in colour, marked “76” on one side and “G” on the other, approximately 8 mm in diameter.

90 mg tablets: biconvex, round, film-coated tablets, white in colour, marked “757” on one side and “G” on the other, approximately 9 mm in diameter.

120 mg tablets: biconvex, round, film-coated tablets, light green in colour, marked “758” on one side and “G” on the other, approximately 10.5 mm in diameter.

30 mg tablets: pack sizes of 5, 28, 30, 90, 98 tablets in blister packs.
60 mg and 90 mg tablets: pack sizes of 7, 14, 20, 28, 30, 50, 90, 100 tablets in blister packs.
120 mg tablets: pack sizes of 2, 5, 7, 14, 20, 28, 30, 90 tablets in blister packs.

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder:

Glenmark Arzneimittel GmbH
Industriestr. 31
82194 Gröbenzell
Germany

Manufacturer:

Glenmark Pharmaceuticals s.r.o.
Fibichova, 143
56617 Vysoke Myto
Czech Republic

Pharmadox Healthcare Ltd.
KW20A Kordin Industrial Park
Paola PLA3000
Malta

For further information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder:

Glenmark Farmacéutica, S.L.U.
C/ Retama 7, 7th floor
28045 Madrid
Spain

This medicinal product is authorised in the EEA Member States under the following names:

Date of the most recent review of the leaflet: November 2016

Detailed information about this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)